MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Climb Bio Inc. (NASDAQ: CLYM), formerly, Eliem Therapeutics, Inc. (NASDAQ: ELYM)*
Finance & Acquisitions: Eliem
Parents
Climb Bio Inc. (NASDAQ: CLYM), formerly, Eliem Therapeutics, Inc. (NASDAQ: ELYM)*
Children
2021: Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs
2021: Eliem funding led by RA Capital Management, Access Biotechnology and Intermediate Capital Group
2021: Eliem raises $60M to take neuro programs to series of data drops
Jumps
*Key People: Eliem Therapeutics
Organization & Developments: Eliem